Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced that the ...

This may be related to the in vitro cell culture model showing that ASFV proliferation was far less vigorous in RZJ/IBM cell cultures compared to IPKM cell cultures. Therefore, detailed ...

IBM looks like a good proving ground for ulviprubart’s potential. The disease is driven by T-cell attacks on muscle fibers that lead to loss of hand function and ability to walk. In 2019 ...

ARM® Logic IP solutions are the ideal choice for advanced, deep submicron SoC designs. The Standard Cell Libraries are complemented by Power Management Kit and ECO Kit extensions, delivering optimal ...